Biberach an der Riss, Germany

Bojan Bister


Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Vienna, AT (2014)
  • Biberach an der Riss, DE (2015)

Company Filing History:


Years Active: 2014-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bojan Bister: Innovator in Anticancer Compounds

Introduction

Bojan Bister is a notable inventor based in Biberach an der Riss, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer compounds. With a total of 2 patents to his name, Bister is recognized for his innovative approaches to cancer therapy.

Latest Patents

Bister's latest patents focus on dual Aurora kinase/MEK inhibitors, which are crucial in the treatment of cancer. The invention describes these compounds and their therapeutic applications, showcasing his commitment to advancing cancer treatment options. The compounds are defined by a general formula (1), highlighting the specificity and potential effectiveness of his inventions.

Career Highlights

Bojan Bister is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work there emphasizes the importance of research and development in creating effective medical solutions. Bister's dedication to innovation in the pharmaceutical industry has positioned him as a key figure in the fight against cancer.

Collaborations

Bister has collaborated with esteemed colleagues, including Stephan Karl Zahn and Patrizia Sini. These partnerships reflect the collaborative nature of scientific research and the importance of teamwork in achieving groundbreaking results.

Conclusion

Bojan Bister's contributions to the field of anticancer compounds demonstrate his innovative spirit and commitment to improving cancer therapies. His work at Boehringer Ingelheim International GmbH and his patents highlight the impact of his research on the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…